logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
31/07/2025
Italian Minister of Economy stated that UniCredit Bank's investments in Russia through its local subsidiary could expose the group to the risk of international sanctions.
Latest
1 m ago
Pryian completed nearly $50 million in Series C financing.
2 m ago
Hong Kong's retail sales volume in June fell by 0.3% on a yearly basis, compared to an expected growth of 0.2% and the previous value of 1.90%.
2 m ago
In September, the official selling price of Omani crude oil was calculated at $71.2 per barrel, an increase of $1.83 from August's $69.37 per barrel.
2 m ago
Shutai Shen (300204.SZ) BDB-001 Injection (indications for ANCA-associated vasculitis) Phase I/II Clinical Study Summary Report
2 m ago
Li Shi Pharmaceutical Factory (00950.HK): Socazolimab has been approved by the National Medical Products Administration for use in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer in mainland China.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.